Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02019251 · ClinicalTrials.gov registry record · Phase 1
Lung Transplant Subjects Using 19F MRI
A Phase 1 study, sponsored by Hal C Charles.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT02019251: Completed Phase 1 study, sponsored by Hal C Charles.
NCT02019251 is a Phase 1 study that has completed, run by Hal C Charles. The registered enrollment target is 6 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02019251, a Phase 1 study, has completed, sponsored by Hal C Charles.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
The goal of this study is to evaluate the utilization of conventional 'thermally' polarized perfluorinated gases mixed with oxygen as inhaled inert contrast agents to image the airway spaces in subjects who have undergone single or double lung transplantation. This is an open label study expanding on current work here at Duke. Images will be obtained using 19F MRI during wash-in and washout for evaluation of ventilation efficiency.
Interventions
- DEVICE MRI
- DRUG perfluorinated gas/oxygen mixture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2013-12 |
| Est. Completion | 2014-08 |
| Phase | Phase 1 |
What the finished NCT02019251 record still lists
NCT02019251 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 2 interventions - of which MRI is the first listed.
NCT02019251 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02019251 about?
NCT02019251 is a clinical study titled "Lung Transplant Subjects Using 19F MRI". The goal of this study is to evaluate the utilization of conventional 'thermally' polarized perfluorinated gases mixed with oxygen as inhaled inert contrast agents to image the airway spaces in subjects who have undergone single or double lung transplantation. This is an open label study expanding o...
What is the current status of trial NCT02019251?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2013-12. Estimated completion is 2014-08.
What interventions are being tested in trial NCT02019251?
The interventions under investigation include: MRI (DEVICE), perfluorinated gas/oxygen mixture (DRUG).
Who is sponsoring clinical trial NCT02019251?
This trial is sponsored by Hal C Charles, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02019251's enrollment target sits among peer trials
6 1974th of 2000 higher than 12 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia